Zdrowie i gospodarka · 07/05/2026
FDA Renews Blood Products Advisory Committee for 2 Years
The FDA has renewed the Blood Products Advisory Committee for an additional 2 years, with the new charter set to expire on May 13, 2028.
Zdrowie i gospodarka · 07/05/2026
The FDA has renewed the Blood Products Advisory Committee for an additional 2 years, with the new charter set to expire on May 13, 2028.